Your session is about to expire
← Back to Search
Device
MyoVista wavECG for Health Screening
N/A
Waitlist Available
Led By Partho Sengupta, MD
Research Sponsored by Heart Test Laboratories, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights
Study Summary
This trial is testing a new device that may help detect heart problems. The study will be conducted on subjects who have been enrolled in prior registry studies.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Diagnostic Performance
Trial Design
1Treatment groups
Experimental Treatment
Group I: MyoVista wavECGExperimental Treatment1 Intervention
Single arm - subjects meeting the inclusion, exclusion and screening criteria will receive a MyoVista wavECG and a trans-thoracic echocardiogram.
Find a Location
Who is running the clinical trial?
Heart Test Laboratories, Inc.Lead Sponsor
3 Previous Clinical Trials
975 Total Patients Enrolled
Partho Sengupta, MDPrincipal InvestigatorRutgers Robert Wood Johnson Medical School
4 Previous Clinical Trials
1,398 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many participants are invited to this experiment?
"Affirmative. Data hosted on clinicaltrials.gov affirms that this medical study, initially posted on June 1st 2022, is actively recruiting individuals. Approximately 50 participants must be recruited from a single healthcare facility."
Answered by AI
Are there any openings available for participation in this research?
"Clinicaltrials.gov reveals that this research is actively recruiting participants, with the trial having been initiated on June 1st 2022 and amended most recently on August 1st of the same year."
Answered by AI
Who else is applying?
What state do they live in?
Texas
How old are they?
18 - 65
What site did they apply to?
University of Texas Medical Center
What portion of applicants met pre-screening criteria?
Met criteria
Share this study with friends
Copy Link
Messenger